Using e-Bug classroom education to boost HPV vaccine consent in a middle school

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a non-interventional observational pilot using aggregated, anonymised vaccination data collected routinely by ARS PACA for the 2023–2024 and 2024–2025 national school-based HPV vaccination campaigns. The pilot school in the Alpes-Maritimes department had teachers and the school nurse already using e-Bug resources as part of routine health education; no new intervention was introduced or modified for research purposes. Aggregated vaccination consent and uptake from the pilot school are compared with departmental-level outcomes to describe whether upstream classroom education may be associated with differences in parental consent and vaccination coverage. No individual-level data or direct recruitment of students or families occurred for this analysis.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* No individual participants are enrolled. The study uses only aggregated, anonymised vaccination data routinely collected by ARS PACA

Exclusion Criteria:

* Not applicable. No individual-level inclusion or exclusion criteria are defined, as no participants are enrolled.

Where it's running

• CHU de NICE
  Nice, Alpes Maritimes, France Recruiting

Study contacts

• Study coordinator: Laure Hermet
• Email: hermet.l@chu-nice.fr
• Phone: 0492039007

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Evaluating the Gardasil-9 HPV vaccine in adults with HIV

  This study is testing how well the Gardasil-9 HPV vaccine works for adults with well-controlled HIV to see if their immune response is similar to those without HIV.

  Recruiting Phase 4 Louisiana State University Health Sciences Center in New Orleans · New Orleans, Louisiana · NCT05266898

• Transtheoretical Model education to improve HPV vaccine knowledge and readiness in first-year nursing students

  This program will try a Transtheoretical Model-based education to see if it increases first-year nursing students' HPV knowledge and makes them more ready to get the HPV vaccine.

  Recruiting Cukurova University · Adana, CUKUROVA and 1 other locations · NCT07248904

• Treatment of Recurrent Respiratory Papillomatosis with PRGN-2012

  This study is testing a new treatment called PRGN-2012 in adults with recurrent respiratory papillomatosis to see if it helps reduce their symptoms after multiple surgeries.

  Recruiting at 3 sites Phase 4 Precigen, Inc · Atlanta, Georgia and 2 other locations · NCT06538480

• Improving HPV vaccination rates in rural communities

  This study is testing different ways to help parents in rural North Central Florida get their kids aged 9 to 12 vaccinated against HPV to see if it can improve vaccination rates.

  Recruiting University of Florida · Gainesville, Florida · NCT06535139

• Treatment with STAR0602 for advanced solid tumors

  This study is testing a new treatment called STAR0602 to see if it can help people with advanced solid tumors by looking at how safe it is and how well it works.

  Recruiting at 16 sites Phase 1/2 Marengo Therapeutics, Inc. · Sacramento, California and 18 other locations · NCT05592626

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.